Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000244827 | SCV000319837 | likely benign | Cardiovascular phenotype | 2015-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001528554 | SCV000535222 | likely benign | not provided | 2020-11-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000457381 | SCV000557813 | likely benign | Primary dilated cardiomyopathy | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001528554 | SCV001740451 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528554 | SCV001972346 | likely benign | not provided | no assertion criteria provided | clinical testing |